GRIA2 and Alzheimer disease: For instance, we have demonstrated that the diffusional trapping and synaptic anchoring of endogenous GluA2-containing AMPARs—likely comprising GluA1/GluA2 and GluA2/GluA3 heteromers—are disrupted in AD models [63].